SOLUBLE INTEGRIN ALPHA-4 MUTANT

摘要

The present invention addresses the problem of providing a novel substance capable of interfering with various functions of integrin ±4, and/or providing a novel substance capable of interfering with both integrin ±4 and integrin ±9. The present invention provides an integrin ±4 mutant peptide having one portion of the extracellular domain of human integrin ±4, and the like, and in concrete terms relates to a peptide and the like having the amino acid sequence of Sequence No. 4 through 9, and a pharmaceutical composition comprising as the active ingredient the same peptide.